<DOC>
	<DOCNO>NCT02600247</DOCNO>
	<brief_summary>This study aim compare effectiveness duloxetine total knee arthroplasty Central sensitization patient . Central sensitization play important role chronic pain experience osteoarthritis patients.Elimination nociceptive input damage joint total joint arthroplasty always follow complete resolution symptom . Patients high level preoperative pain low pain threshold high risk persistent pain total knee arthroplasty ( TKA ) , interpret evidence central sensitization . Thus , presence central sensitization surgery Osteoarthritis patient may important contribute factor postoperative pain versus adequate analgesia . Preclinical model central sensitization suggest duloxetine effective treatment persistent pain . Investigators compare pain follow TKA central sensitization patient duloxetine group ( n=50 ) non-duloxetine group ( n=84 ) . Investigators classify central sensitization patient central sensitization inventory divide central sensitization patient 2 group ( duloxetine non-duloxetine group ) randomly . Investigators check visual assessment scale preoperative , postoperative 1 , 2,6,12 week . All participant receive postoperative pain control TKA use pain control regimen except duloxetine .</brief_summary>
	<brief_title>Effects Duloxetine Pain Relief After Total Knee Arthroplasty Central Sensitization Patient</brief_title>
	<detailed_description>Both group participant receive pain control regimens follow : Preemptive analgesia : celebrex celecoxib , Lyrica Pregabalin , Patient control analgesia ( postoperation 28 hour ) , During admission : celebrex 200mg # 1 , Ircodon 5mg 2Tablets # 2 , Ultracet 2T # 2 ( Postoperation 1 week ) Discharge medication : celebrex 200mg 1Capsule # 1 x 5 week , Ultracet 2T # 2 x 1 week Drug generic name : celecoxib ( celebrex ) , Pregabalin ( Lyrica ) , acetaminophen/tramadol ( ultracet ER ) , oxycodone ( Ircodon )</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Patients total knee arthroplasty medicare insurance CSI ( Central sensitization inventory ) &gt; 40 ( Central sensitization patient ) Rheumatoid arthritis Other inflammatory arthritis Neuropsychiatric patient Allergy intolerance study medication Patients ASA ( American society anesthesiologist ) classification IV ( angina , congestive heart failure , dementia , cerebrovascular accident ) Chronic gabapentin pregabalin use ( regular use longer 3 month ) Chronic opioid use ( take opioids longer 3 month ) Alcohol , drug abuser Narcotics addiction</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Duloxetine</keyword>
</DOC>